CONCORD, Ohio--(BUSINESS WIRE)--Ricerca Biosciences, a preclinical development contract research organization (CRO) providing services to the biopharmaceutical industry, is pleased to announce the addition of Douglas K. Fuhrer, Ph.D., DABT, as senior director of drug safety.
